Puneet Souda
Stock Analyst at Leerink Partners
(4.26)
# 1,450
Out of 5,076 analysts
929
Total ratings
46.3%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Puneet Souda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Reiterated: Buy | $80 | $57.59 | +38.91% | 50 | Sep 29, 2026 | |
| ILMN Illumina | Reiterated: Buy | $210 → $300 | $269.42 | +11.35% | 83 | Sep 29, 2026 | |
| TWST Twist Bioscience | Reiterated: Buy | $160 → $190 | $139.92 | +35.79% | 34 | Sep 29, 2026 | |
| TXG 10x Genomics | Reiterated: Hold | $40 → $90 | $71.55 | +25.79% | 13 | Sep 29, 2026 | |
| SVRN SVRN, Inc. | Reiterated: Buy | n/a | $35.32 | - | 2 | Sep 17, 2026 | |
| NTRA Natera | Reiterated: Buy | $330 | $403.95 | -18.31% | 66 | Aug 7, 2026 | |
| RVTY Revvity | Reiterated: Buy | n/a | $158.77 | - | 15 | Jul 17, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | $73 | $72.55 | +0.62% | 44 | Jun 25, 2026 | |
| GH Guardant Health | Reiterated: Buy | n/a | $169.08 | - | 67 | Jun 2, 2026 | |
| ALMR Alamar Biosciences | Initiated Coverage: Buy | $35 | $30.69 | +14.04% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $14 → $25 | $16.59 | +50.69% | 50 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $500 → $580 | $673.82 | n/a | 50 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $235 | $230.50 | n/a | 18 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $176.93 | n/a | 42 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $2.86 | n/a | 60 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $173.07 | n/a | 39 | Sep 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.66 | n/a | 13 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $47.93 | n/a | 40 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $10 → $16 | $17.98 | n/a | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $11.49 | n/a | 40 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 | $5.82 | n/a | 33 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $33.08 | n/a | 48 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $453.67 | n/a | 38 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.08 | n/a | 1 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.92 | n/a | 1 | Jun 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $11.82 | n/a | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $33.82 | n/a | 1 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $34.93 | n/a | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $21.09 | n/a | 1 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.000001 | n/a | 7 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $0.0006 | n/a | 9 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $25.30 | n/a | 1 | Oct 20, 2014 |
Bruker
Sep 29, 2026
Reiterated: Buy
Price Target: $80
Current: $57.59
Upside: +38.91%
Illumina
Sep 29, 2026
Reiterated: Buy
Price Target: $210 → $300
Current: $269.42
Upside: +11.35%
Twist Bioscience
Sep 29, 2026
Reiterated: Buy
Price Target: $160 → $190
Current: $139.92
Upside: +35.79%
10x Genomics
Sep 29, 2026
Reiterated: Hold
Price Target: $40 → $90
Current: $71.55
Upside: +25.79%
SVRN, Inc.
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.32
Upside: -
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $330
Current: $403.95
Upside: -18.31%
Revvity
Jul 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $158.77
Upside: -
Bio-Techne
Jun 25, 2026
Downgraded: Hold
Price Target: $73
Current: $72.55
Upside: +0.62%
Guardant Health
Jun 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $169.08
Upside: -
Alamar Biosciences
May 12, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $30.69
Upside: +14.04%
Apr 29, 2026
Upgraded: Buy
Price Target: $14 → $25
Current: $16.59
Upside: +50.69%
Oct 23, 2025
Reiterated: Buy
Price Target: $500 → $580
Current: $673.82
Upside: n/a
Oct 22, 2025
Reiterated: Buy
Price Target: $235
Current: $230.50
Upside: n/a
Sep 11, 2025
Reiterated: Buy
Price Target: $200
Current: $176.93
Upside: n/a
Sep 10, 2025
Reiterated: Hold
Price Target: $6
Current: $2.86
Upside: n/a
Sep 1, 2025
Reiterated: Buy
Price Target: $140
Current: $173.07
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $10
Current: $4.66
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $45
Current: $47.93
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: $10 → $16
Current: $17.98
Upside: n/a
Aug 6, 2025
Upgraded: Buy
Price Target: $7 → $12
Current: $11.49
Upside: n/a
Aug 6, 2025
Reiterated: Hold
Price Target: $9
Current: $5.82
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $35
Current: $33.08
Upside: n/a
Aug 5, 2025
Reiterated: Buy
Price Target: $340
Current: $453.67
Upside: n/a
Jul 29, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.08
Upside: n/a
Jun 1, 2025
Reiterated: Buy
Price Target: n/a
Current: $3.92
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $5
Current: $11.82
Upside: n/a
May 7, 2024
Reiterated: Buy
Price Target: n/a
Current: $33.82
Upside: n/a
Dec 19, 2023
Reiterated: Buy
Price Target: n/a
Current: $34.93
Upside: n/a
Apr 29, 2022
Reiterated: Buy
Price Target: $16
Current: $21.09
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Aug 24, 2021
Reiterated: Buy
Price Target: $3
Current: $0.0006
Upside: n/a
Oct 20, 2014
Reiterated: Buy
Price Target: $80
Current: $25.30
Upside: n/a